Ginsenoside Rg2 protects cardiomyocytes against trastuzumab‑induced toxicity by inducing autophagy
G Liu, X Qi, X Li, F Sun - Experimental and Therapeutic …, 2021 - spandidos-publications.com
Trastuzumab (TZM) significantly improves the outcomes of patients with breast cancer;
however, it is associated with severe cardiotoxicity. Ginsenoside Rg2 was reported to exert …
however, it is associated with severe cardiotoxicity. Ginsenoside Rg2 was reported to exert …